Severity-associated cross-reactive anti-sarbecovirus antibody responses in COVID-19 convalescents and isolation of a dual-targeting monoclonal antibody with cross-neutralizing activity
Qian Wu, Ling Niu, Yueyang Zhang, Tan Tan, Yuchen Yang, Shuang Li, Bo Liu, Jun Chen, Chun Huang, Qijie Wang, Yabin Hu · 2026
Read Severity-associated cross-reactive anti-sarbecovirus antibody responses in COVID-19 convalescents and isolation of a dual-targeting monoclonal antibody with cross-neutralizing activity by Qian Wu, Ling Niu, Yueyang Zhang, Tan Tan, Yuchen Yang, Shuang Li, Bo Liu, Jun Chen, Chun Huang, Qijie Wang, Yabin Hu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13310989.txt.
Description
Qian Wu led a 2026 study on cross reactive antibodies after COVID-19 and a dual targeting lab antibody. Related animal coronaviruses threaten future outbreaks, so broad antibodies are prized. Blood from recovered patients was tested against seven related spike proteins, and memory cells were mined for strong clones.
Plasma came from 67 recovered patients, with 17 severe and 50 non severe cases. Severe cases held broader and stronger cross responses that lasted a year and rose after vaccination. One cloned antibody gripped both spike parts at once and blocked two viruses, though weakly. The clone proves a dual grip plan for wider design.
Catalog record
| CREATOR | Qian Wu, Ling Niu, Yueyang Zhang, Tan Tan, Yuchen Yang, Shuang Li, Bo Liu, Jun Chen, Chun Huang, Qijie Wang, Yabin Hu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39534 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |